Showing posts with label compliance. Show all posts
Showing posts with label compliance. Show all posts

Saturday, December 28, 2024

Overcoming AI’s Nagging Trust And Ethics Issues; Forbes, December 28, 2024

 Joe McKendrick, Forbes ; Overcoming AI’s Nagging Trust And Ethics Issues

"Trust and ethics in AI is what is making business leaders nervous. For example, at least 72% of executives responding to a recent surveyfrom the IBM Institute for Business Value say they “are willing to forgo generative AI benefits due to ethical concerns.” In addition, more than half (56%) indicate they are delaying major investments in generative AI until there is clarity on AI standards and regulations...

"Today, guardrails are a growing area of practice for the AI community given the stochastic nature of these models,” said Ross. “Guardrails can be employed for virtually any area of decisioning, from examining bias to preventing the leakage of sensitive data."...

The situation is not likely to change soon, Jeremy Rambarran, professor at Touro University Graduate School, pointed out. “Although the output that's being generated may be unique, depending on how the output is being presented, there's always a chance that part of the results may not be entirely accurate. This will eventually change down the road as algorithms are enhanced and could eventually be updated in an automated manner.”...

How can AI be best directed to be ethical and trustworthy? Compliance requirements, of course, will be a major driver of AI trust in the future, said Rambarran. “We need to ensure that AI-driven processes comply with ethical guidelines, legal regulations, and industry standards. Humans should be aware of the ethical implications of AI decisions and be ready to intervene when ethical concerns arise.”

Friday, October 4, 2024

Beyond the hype: Key components of an effective AI policy; CIO, October 2, 2024

  Leo Rajapakse, CIO; Beyond the hype: Key components of an effective AI policy

"An AI policy is a living document 

Crafting an AI policy for your company is increasingly important due to the rapid growth and impact of AI technologies. By prioritizing ethical considerations, data governance, transparency and compliance, companies can harness the transformative potential of AI while mitigating risks and building trust with stakeholders. Remember, an effective AI policy is a living document that evolves with technological advancements and societal expectations. By investing in responsible AI practices today, businesses can pave the way for a sustainable and ethical future tomorrow."

Friday, February 18, 2022

The government dropped its case against Gang Chen. Scientists still see damage done; WBUR, February 16, 2022

Max Larkin, WBUR ; The government dropped its case against Gang Chen. Scientists still see damage done

"When federal prosecutors dropped all charges against MIT professor Gang Chen in late January, many researchers rejoiced in Greater Boston and beyond.

Chen had spent the previous year fighting charges that he had lied and omitted information on U.S. federal grant applications. His vindication was a setback for the "China Initiative," a controversial Trump-era legal campaign aimed at cracking down on the theft of American research and intellectual property by the Chinese government.

Researchers working in the United States say the China Initiative has harmed both their fellow scientists and science itself — as a global cooperative endeavor. But as U.S.-China tensions remain high, the initiative remains in place."

Thursday, May 20, 2021

A Little-Known Statute Compels Medical Research Transparency. Compliance Is Pretty Shabby.; On The Media, April 21, 2021

 On The Media; A Little-Known Statute Compels Medical Research Transparency. Compliance Is Pretty Shabby.

"Evidence-based medicine requires just that: evidence. Access to the collective pool of knowledge produced by clinical trials is what allows researchers to safely and effectively design future studies. It's what allows doctors to make the most informed decisions for their patients.

Since 2007, researchers have been required by law to publish the findings of any clinical trial with human subjects within a year of the trial's conclusion. Over a decade later, even the country's most well-renown research institutions sport poor reporting records. This week, Bob spoke with Charles Piller, an investigative journalist at Science Magazine who's been documenting this dismal state of affairs since 2015. He recently published an op-ed in the New York Times urging President Biden to make good on his 2016 "promise" to start withholding funds to force compliance."